Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Mini Rev Med Chem ; 22(11): 1545-1558, 2022.
Article in English | MEDLINE | ID: mdl-34711161

ABSTRACT

Dihydropyrimidinones (DHPMs) are heterocycles obtained by the multicomponent Biginelli reaction. Recently, new synthetic protocols have allowed us to explore functionalisation at less explored positions of DHPMs, such as the N1 position. In this context, a full literature survey of N1- substituted DHPMs was performed. We analysed 27 papers and identified 379 compounds with substituents at the N1 position, most of them with alkyl groups, and a total of 28% compounds with aromatic substituents attached at the N1 position. N1-substituted DHPMs were explored mainly due to their effects on cancer cell proliferation via numerous targets, such as kinesin Eg5, heat shock protein 70, heat shock protein 90, and the epidermal growth factor receptor. Similarity analyses were performed using the data of 379 DHPMs from different cheminformatic approaches, i.e., chemical property correlations, principal component analysis, similarity networks, and compound clustering.


Subject(s)
Pyrimidinones , Cell Proliferation , Pyrimidinones/chemistry
2.
Mini Rev Med Chem ; 21(13): 1701-1717, 2021.
Article in English | MEDLINE | ID: mdl-33372872

ABSTRACT

The complexity of Chagas disease is still a challenge in endemic regions and an emergent public health problem in non-endemic countries. The causative agent of this neglected tropical disease, Trypanosoma cruzi, is mainly transmitted by triatomine vectors and possesses multiple epidemiologically important strains. Current chemotherapeutics are outdated and their limited efficacy is one of the major reasons for treatment discontinuation. In this context, the development of novel, safe and economically accessible antichagasic drugs is required. Various classes of heterocycles and natural compounds have been described as potential antichagasic scaffolds, and coumarins are no exception. These versatile compounds have a wide spectrum of biological activities, and numerous natural and synthetic coumarins have been reported with antichagasic potential. This review aims to discuss the available literature between 2001 and 2020 regarding natural and synthetic coumarins with anti- Trypanosoma cruzi activity. Moreover, some of the studies herein comprised are dedicated to the potential of coumarins to inhibit promising targets in Trypanosoma cruzi.


Subject(s)
Biological Products/chemistry , Chagas Disease/drug therapy , Coumarins/chemistry , Trypanocidal Agents/therapeutic use , Trypanosoma cruzi/physiology , Biological Products/pharmacology , Biological Products/therapeutic use , Chagas Disease/parasitology , Coumarins/chemical synthesis , Coumarins/pharmacology , Coumarins/therapeutic use , Humans , Life Cycle Stages/drug effects , Structure-Activity Relationship , Trypanocidal Agents/chemistry , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/isolation & purification
3.
Eur J Med Chem ; 203: 112514, 2020 Oct 01.
Article in English | MEDLINE | ID: mdl-32668302

ABSTRACT

The neglected tropical disease leishmaniasis is still a major public health problem that affects millions of people worldwide. Related to poor-living conditions, this vector-borne disease presents multiple clinical manifestations - from asymptomatic to systemic conditions. The protozoans of the genus Leishmania are the etiologic agents transmitted through the bite of sandflies, the main vectors. Current pharmacological interventions are outdated and present several drawbacks, thus the search for new antileishmanial compounds is imperative. Medicinal chemists have been continuously investigating for new alternatives to combat leishmaniasis, and coumarins play a pivotal role in this search. Various biological properties have been described owing to coumarin's structural versatility combined with its unique features, including antileishmanial activity. The aim of this review is to highlight the most relevant studies between 1997 and 2020 and provide a guide for the development of new antileishmanial coumarins. Naturally occurring and synthetically designed coumarins are comprised in this review, along with a structure-activity relationship to provide an insight for further development of coumarins with antileishmanial activity.


Subject(s)
Antiprotozoal Agents/pharmacology , Biological Products/pharmacology , Coumarins/pharmacology , Leishmania/drug effects , Animals , Antiprotozoal Agents/chemical synthesis , Coumarins/chemical synthesis , Humans
SELECTION OF CITATIONS
SEARCH DETAIL